Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

91 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.

NCT03578367

Conditions
Bone Marrow Diseases, CML, Chronic Disease, +13 more
Locations
  • Georgia Regents University Augusta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Montreal, Quebec, Canada
View all 30 locations
View Trial Details
Completed

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

NCT02467270

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Indiana Blood & Marrow Transplantation Indianapolis, Indiana, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
  • Michigan Medicine Ann Arbor, Michigan, United States
View all 86 locations
View Trial Details
Completed

Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS

NCT03066648

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Oregon Health Sciences University Main Center Portland, Oregon, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Novartis Investigative Site Melbourne, Victoria, Australia
View Trial Details
Completed

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

NCT02577406

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Isocitrate Dehydrogenase, +4 more
Locations
  • Local Institution - 121 Miami, Florida, United States
  • University of Florida Health Cancer Center at Orlando Health Orlando, Florida, United States
  • Local Institution - 111 Chicago, Illinois, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View all 93 locations
View Trial Details

Related conditions